Figure 3.

Small-molecule inhibitors of Spike (S) protein receptor-binding domain (RBD) and angiotensin-converting enzyme 2 (ACE2) entry and their targets. ^{HYPERLINK "SPS:refid::bib35_bib36_bib37_bib38_bib39_bib40_bib41_bib42_bib43_bib44_bib45" 35–45.}